Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
David L. Lacey currently holds 31,250 shares of Arcus Biosciences, Inc. (RCUS), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, David L. Lacey has been a net neutral trader of RCUS stock. They have purchased $0 and sold $0 worth of shares.
David L. Lacey's most recent insider trade was on May 15, 2026, when they sold 31,250 shares at $0.00 per share.
David L. Lacey serves as Executive at Arcus Biosciences, Inc. (RCUS). They have executed 7 insider transactions totaling $0 over their tenure at the company.
David L. Lacey holds the position of Executive at Arcus Biosciences, Inc., where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 5 years and currently hold a stake valued at $0.
David L. Lacey has shown a balanced trading pattern, with $0 in total purchases and $0 in total sales across all transactions. Their most recent activity indicates a balanced approach to trading.
The largest transaction by David L. Lacey was on May 15, 2026, when they purchased $0 worth of NRIX shares. This transaction involved 31,250 shares at N/A per share.
David L. Lacey currently owns 31,250 shares of Arcus Biosciences, Inc. (RCUS), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of David L. Lacey's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. David L. Lacey has 7 Form 4 filings on record as an insider at Arcus Biosciences, Inc..
Set alerts for David L. Lacey and 40,000+ other insiders.